STOCKHOLM, April 28, 2022 /PRNewswire/ Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820 (the "Company"), are hereby summoned to the Annual General Meeting on Wednesday
/PRNewswire/ Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820 (the "Company"), are hereby summoned to the Annual General Meeting on.